This statistic shows the specialty medicines revenues breakdown of pharmaceutical company Teva from 2022 to 2024, by product. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2024, top product Austedo generated revenues of around 1.64 billion U.S. dollars.
Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Teva Pharmaceutical, & U.S. Securities and Exchange Commission. (February 5, 2025). Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved February 14, 2025, from https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed
Teva Pharmaceutical, und U.S. Securities and Exchange Commission. "Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars)." Chart. February 5, 2025. Statista. Accessed February 14, 2025. https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed
Teva Pharmaceutical, U.S. Securities and Exchange Commission. (2025). Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: February 14, 2025. https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed
Teva Pharmaceutical, and U.S. Securities and Exchange Commission. "Leading Specialty Medicines of Teva Pharmaceutical Industries by Revenue from 2022 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 5 Feb 2025, https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed
Teva Pharmaceutical & U.S. Securities and Exchange Commission, Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed (last visited February 14, 2025)
Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2022 to 2024 (in million U.S. dollars) [Graph], Teva Pharmaceutical, & U.S. Securities and Exchange Commission, February 5, 2025. [Online]. Available: https://www.statista.com/statistics/539681/teva-pharmaceutical-industries-specialty-medicines-revenues/?__sso_cookie_checker=failed
